Clearside Biomedical
CLSD
CLSD was delisted on the 28th of November, 2025.
1 hedge funds and large institutions have $19.1K invested in Clearside Biomedical in 2025 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 26 closing their positions.
0.19% less ownership
Funds ownership: 0.7% → 0.52% (-0.19%)
96% less funds holding
Funds holding: 26 → 1 (-25)
96% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 26
99% less capital invested
Capital invested by funds: $2.18M → $19.1K (-$2.17M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DS
DRW Securities
Chicago,
Illinois
|
+$95.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$881K |
| 2 |
CG
Carmignac Gestion
Paris,
France
|
-$399K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
-$209K |
| 4 |
BlackRock
New York
|
-$165K |
| 5 |
Renaissance Technologies
New York
|
-$100K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AF
26
Allworth Financial
Folsom,
California
| – | -$12 | -3 | Closed |
|
27
Citigroup
New York
| – | -$4 | -1 | Closed |
|
CLSD Hedge Fund Activity: Q4 2025 in Review
1 of the 8,225 institutional investors tracked by Wall St. Rank reported a position in Clearside Biomedical (CLSD) for Q4 2025, worth a combined $19.1K — down 99% from $2.18M a quarter earlier.
Sellers outnumbered buyers: 26 funds closed out of CLSD and 1 opened new positions — a net loss of 25 holders — while 0 trimmed existing stakes and 0 added.
The largest buyer was DRW Securities, opening a new position worth an estimated $95.6K. The largest seller was Vanguard Group, exiting entirely with an estimated $881K sold.
- 1 institutional investor held Clearside Biomedical (CLSD) as of Q4 2025, down from 26 in Q3 2025.
- Funds reported $19.1K of Clearside Biomedical stock for Q4 2025, down 99% quarter-over-quarter.
- 1 fund opened new Clearside Biomedical positions in Q4 2025 and 26 closed out, a net change of -25 holders.
- The largest Clearside Biomedical buyer in Q4 2025 was DRW Securities, an estimated $95.6K added.
- The largest Clearside Biomedical seller in Q4 2025 was Vanguard Group, an estimated $881K sold.
Based on aggregated 13F filings for Q4 2025.